首页 | 本学科首页   官方微博 | 高级检索  
     


Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites
Authors:O. El-Kabbani  A. Podjarny
Affiliation:(1) Department of Medicinal Chemistry, Victorian College of Pharmacy, Monash University, (Parkville Campus), 381 Royal Parade, Parkville, Victoria, 3052, Australia;(2) Department of Structural Biology and Genomics, IGBMC, ULP, INSERM, UMR 7104 du CNRS, 1 rue Laurent Fries, 67404 Illkirch, France
Abstract:Aldose reductase and aldehyde reductase belong to the aldo-keto reductase superfamily of enzymes whose members are responsible for a wide variety of biological functions. Aldose reductase has been identified as the first enzyme involved in the polyol pathway of glucose metabolism which converts glucose into sorbitol. Glucose over-utilization through the polyol pathway has been linked to tissue-based pathologies associated with diabetes complications, which make the development of a potent aldose reductase inhibitor an obvious and attractive strategy to prevent or delay the onset and progression of the complications. Structural studies of aldose reductase and the homologous aldehyde reductase in complex with inhibitor were carried out to explain the difference in the potency of enzyme inhibition. The aim of this review is to provide a comprehensive summary of previous studies to aid the development of aldose reductase inhibitors that may have less toxicity problems than the currently available ones. Received 4 December 2006; received after revision 12 February 2007; accepted 20 April 2007
Keywords:Aldose reductase  aldehyde reductase  polyol pathway  glucose metabolism  enzyme inhibition  drug design  diabetes
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号